Streetbeat News

Products Services

SMCI

Super Micro Computer Inc (NASDAQ:SMCI) shares fell by 2.6% after a strong previous week driven by positive U.S. retail sales data and a smaller-than-expected increase in producer prices. The stock's recent surge was also supported by Soros Fund Management's purchase of shares. The cooling inflation may lead to lower interest rates, benefiting companies like SMCI with reduced borrowing costs.

Portfolio Pulse from Henry Khederian

August 19, 2024 | 4:16 pm

TTOO

T2 Biosystems has received approval from the Australian Therapeutic Goods Administration for its T2Candida in vitro diagnostic test. This test is designed to detect sepsis-causing fungal pathogens directly from whole blood, potentially improving patient outcomes by enabling faster diagnosis and treatment.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 4:16 pm

BTCUSD

The cryptocurrency market is showing bearish signs, with Bitcoin's funding rates dropping significantly, while U.S. equities are at all-time highs. This divergence is due to expectations of rate cuts and economic recovery in traditional markets, contrasting with stress in crypto markets.

Portfolio Pulse from Murtuza Merchant

August 19, 2024 | 4:13 pm

GOVX

VRAX

Virax Biolabs Group Limited (NASDAQ:VRAX) shares surged after the WHO declared mpox a global health emergency. The company distributes diagnostic test kits and is developing T-Cell Test technology. GeoVax Labs, Inc. (NASDAQ:GOVX) is also being monitored by investors. Virax shares rose 204.9% amid volatility.

Portfolio Pulse from Erica Kollmann

August 19, 2024 | 4:12 pm

GLASF

Glass House Brands Inc. is considering diversifying into the hemp sector, leveraging its existing greenhouses. The company reported a record-setting Q2 2024 with $53.9 million in revenue. CEO Kyle Kazan is exploring direct-to-consumer hemp products and sees potential in both cannabis and hemp markets. The move comes amid challenges in California's cannabis market due to over-taxation and falling prices.

Portfolio Pulse from Jelena Martinovic

August 19, 2024 | 4:11 pm

FTXH

IBBQ

IDNA

LGHT

MRNA

NVAX

PFE

The FDA is expected to approve updated COVID-19 vaccines from Moderna, Pfizer, and possibly Novovax this week. This approval is in response to a significant summer outbreak in the U.S. Moderna and Pfizer have vaccines ready for distribution, while Novovax's vaccine will be available later this month. Stocks of these companies and related ETFs have shown gains in anticipation of the approval.

Portfolio Pulse from Michael Juliano

August 19, 2024 | 4:08 pm

GOOGL

Google Cloud has expanded its services in Saudi Arabia, introducing new data sovereignty, security, and AI capabilities in the Dammam region. This includes partnerships with local entities like CNTXT to enhance digital transformation and meet regulatory requirements. The expansion also features the Vertex AI platform and a new online portal for streamlined service access.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 4:07 pm

NCNA

Oppenheimer has issued a buy rating for NuCana (NCNA) with a 12-18 month price target of $150. The note highlights the potential efficacy advantage in progression-free survival from NuCana's Phase 2 trial in metastatic colorectal cancer as a significant positive indicator.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 4:02 pm

DIS

FOX

FOXA

FUBO

WBD

A judge's injunction halting a sports streaming joint venture between Disney, Warner Bros. Discovery, and Fox is seen as a victory for FuboTV. Analysts suggest this could kill the Venu platform, benefiting FuboTV. FuboTV's CEO celebrated the ruling, highlighting the company's growth and commitment to its streaming model.

Portfolio Pulse from Chris Katje

August 19, 2024 | 3:51 pm

AMZN

GOOGL

MSFT

Needham analyst Laura Martin reiterates a Buy rating for Alphabet Inc (GOOGL) with a $210 price target, citing strong macro conditions, political ad spending, and AI integrations. Google and Amazon are seen as leaders in the GenAI space, with significant investments expected in 2024.

Portfolio Pulse from Anusuya Lahiri

August 19, 2024 | 3:46 pm